首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

市場調查報告書

商品編碼

1605703

體載注射器市場，按技術、按應用、按最終用途、按國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

On-body Injectors Market, By Technology, By Application, By End-Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: 2024年12月01日 | 出版商:

AnalystView Market Insights | 英文 372 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

報告要點

2023 年，體載注射器市場規模為 48.97 億美元，2024 年至 2032 年複合年成長率為 14.5%。

體載注射器市場-市場動態

慢性病盛行率上升推動市場成長

體上注射器市場是由糖尿病、類風濕性關節炎和癌症等慢性疾病盛行率上升所推動的，這些疾病需要持續用藥。這些穿戴式裝置使患者能夠以最小的不適自行給藥，從而提高依從性和便利性。技術進步，包括與用於監控和反饋的數位平台的整合，進一步促進了它們的採用。此外，向生物製劑和特殊藥物的轉變增加了對高效能藥物傳遞系統（如體內注射器）的需求。老年人口不斷成長、對微創解決方案的需求以及監管機構的支持等關鍵因素促進了市場的成長。

體載注射器市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 14.5% 左右的複合年成長率成長

根據技術細分，預計基於彈簧的細分市場將在 2023 年顯示最大的市場佔有率

根據應用細分，類風濕性關節炎是2023年的主導類型

按地區分類，北美是 2023 年的主要收入來源

體載注射器市場細分分析：

全球體上注射器市場根據技術、應用、最終用途和地區進行細分。自動注射器市場依技術主要分為兩個部分：彈簧式、馬達驅動式、旋轉幫浦式和膨脹電池式等。基於彈簧的細分市場主導了市場。這些體內注射器為患者和醫療保健提供者提供了許多好處。透過以一致的壓力和速度傳遞藥物，它們可確保準確可靠的劑量，這對於需要精確度的治療尤其重要，例如治療糖尿病的胰島素或治療自體免疫疾病的生物製劑。這種機制最大限度地減少了與手動注射相關的錯誤可能性，提高了治療安全性和效率。他們的控釋系統也支持病患的舒適度和依從性，使其成為各種臨床應用的首選。

基於應用：腫瘤學、糖尿病、心血管疾病、自體免疫疾病等。到 2023 年，糖尿病細分市場將佔據最大的市場佔有率。在腫瘤學中，它們提供精確劑量的化療藥物，以最大限度地減少醫院就診次數。對於糖尿病，它們可確保控制胰島素輸送，為傳統注射提供靈活的替代方案。在心血管疾病中，這些設備可以施用抗凝血劑或其他關鍵藥物來有效控制病情。自體免疫疾病受益於定期生物治療的體內注射器，減少了頻繁臨床就診的需要。此外，它們也用於其他治療領域，如疼痛管理和荷爾蒙治療，提供可靠和個人化的給藥解決方案。

根據最終用途，市場分為家庭護理場所、醫院和診所以及門診手術中心。家庭護理設置細分市場佔據主導地位。體內注射器在家庭護理環境中越來越受歡迎，因為它們允許患者安全、輕鬆地自行給藥。這種便利性減少了頻繁就診的需要，使慢性病患者的治療更容易、更有效率。這些設備在家庭護理領域的興起是推動該領域快速成長的關鍵因素。

體載注射器市場 - 地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太地區、中東和非洲地區。由於對自我給藥藥物系統的需求不斷增加，特別是對於糖尿病和自體免疫疾病等慢性疾病的需求不斷增加，體上注射器市場正在經歷顯著成長。在先進的醫療基礎設施和創新技術的廣泛採用的推動下，北美在市場上佔據主導地位。在政府支持性措施和人口老化不斷加劇的推動下，歐洲緊隨其後。由於醫療保健投資的增加、患者群體的擴大以及對先進給藥系統的認知的提高，亞太地區正在成為關鍵的成長地區。同時，中東、非洲和拉丁美洲呈現穩定成長，這主要得益於醫療保健服務的改善和基礎設施的發展。

體載注射器市場-競爭格局：

身體注射器市場的競爭格局以領先的醫療保健和製藥公司的存在為標誌，推動穿戴式藥物輸送系統的創新。 Medtronic plc、Insulet Corporation、Ypsomed 和 West Pharmaceutical Services 等主要參與者以專為慢性病管理量身定做的先進解決方案主導市場。其他著名公司，如 Enable Injections 和 Becton, Dickinson and Company (BD)，專注於精確、方便用戶使用的設計以及與數位健康平台的整合。合作夥伴關係和收購進一步加劇了競爭，使公司能夠擴大其產品組合併增強其技術能力，以滿足全球不斷成長的患者和醫療保健需求。

介紹
- 按地理位置分類的細分市場佔有率分析
北美洲
- 概述
- 北美體內注射器主要製造商
- 北美市場規模和預測（按國家）
- 北美市場規模和預測（按技術）
- 北美市場規模和預測（按應用）
- 北美市場規模和預測（按最終用途）
- 美國
- 加拿大
歐洲
- 概述
- 歐洲體內注射器主要製造商
- 歐洲市場規模和預測（按國家）
- 歐洲市場規模與預測（按技術）
- 歐洲市場規模和預測（按應用）
- 歐洲市場規模和預測（按最終用途）
- 德國
- 義大利
- 英國
- 法國
- 俄羅斯
- 荷蘭
- 瑞典
- 波蘭
- 歐洲其他地區
亞太地區 (APAC)
- 概述
- 亞太地區體載注射器主要製造商
- 亞太地區市場規模與預測（按國家）
- 亞太地區市場規模與預測（按技術）
- 亞太地區市場規模與預測（按應用）
- 亞太地區市場規模和預測（按最終用途）
- 印度
- 中國
- 日本
- 韓國
- 澳洲
- 泰國
- 印尼
- 菲律賓
- 亞太地區其他地區
拉丁美洲
- 概述
- 拉丁美洲注射器主要製造商
- 拉丁美洲市場規模與預測（按國家）
- 拉丁美洲市場規模與預測（按技術）
- 拉丁美洲市場規模與預測（按應用）
- 拉丁美洲市場規模和預測（按最終用途）
- 巴西
- 墨西哥
- 阿根廷
- 哥倫比亞
- 拉丁美洲其他地區
中東和非洲
- 概述
- 中東和非洲體內注射器主要製造商
- 中東和非洲市場規模及預測（按國家）
- 中東和非洲市場規模及預測（按技術）
- 中東和非洲市場規模及預測（按應用）
- 中東和非洲市場規模和預測（按最終用途）
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 土耳其
- 阿爾及利亞
- 埃及
- MEA 的其餘部分

第 11 章：主要供應商分析 - 體上注射器產業

競爭儀表板
- Competitive Benchmarking
- Competitive Positioning
公司簡介
- Insulet Corporation
- BD (Becton, Dickinson and Company)
- West Pharmaceutical Services, Inc.
- Ypsomed Holding AG
- Medtronic plc
- Enable Injections
- Roche
- Eli Lilly and Company
- Amgen Inc.
- CeQur SA
- Others

第 12 章：360 度分析師視角

第 13 章：附錄

研究方法
參考
縮寫
免責聲明
聯絡我們

簡介目錄

Product Code: ANV4319

REPORT HIGHLIGHT

On-body Injectors Market size was valued at USD 4,897 Million in 2023, expanding at a CAGR of 14.5% from 2024 to 2032.

On-body Injectors are wearable drug delivery devices designed to administer medications subcutaneously over a specific period, offering convenience and precision in chronic disease management. These devices enable self-administration of large-volume biologics and improve patient compliance by reducing the need for frequent hospital visits. With advanced features like programmable dosing, they cater to treatments for conditions such as diabetes, rheumatoid arthritis, and cancer. On-body injectors integrate cutting-edge technology to ensure ease of use, patient comfort, and safety, making them a significant innovation in personalized medicine and home-based healthcare solutions.

On-body Injectors Market- Market Dynamics

Rising prevalence of chronic diseases to fuel market growth

The on-body injectors market is driven by the rising prevalence of chronic diseases such as diabetes, rheumatoid arthritis, and cancer, which require consistent drug administration. These wearable devices enable patients to self-administer medication with minimal discomfort, improving adherence and convenience. Technological advancements, including integration with digital platforms for monitoring and feedback, further boost their adoption. Additionally, the shift toward biologics and specialty medications has increased the need for efficient drug delivery systems like on-body injectors. Key factors such as the growing geriatric population, demand for minimally invasive solutions, and support from regulatory bodies foster the market's growth.

On-body Injectors Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.5% over the forecast period (2024-2032)

Based on Technology segmentation, spring-based segment were predicted to show maximum market share in the year 2023

Based on Application segmentation, rheumatoid arthritis was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

On-body Injectors Market- Segmentation Analysis:

The Global On-body Injectors Market is segmented on the basis of Technology, Application, End-Use, and Region. The auto-injector market is primarily divided into two segments based on Technology: Spring-based, Motor-driven, Rotary Pump and Expanding Battery and Other. The spring-based segment dominated the market. These on-body injectors offer numerous benefits to patients and healthcare providers. By delivering medication at consistent pressure and speed, they ensure accurate and reliable dosing, which is particularly essential for therapies requiring precision, such as insulin for diabetes or biologics for autoimmune diseases. This mechanism minimizes the potential for errors associated with manual injections, enhancing treatment safety and efficiency. Their controlled delivery system also supports patient comfort and compliance, making them a preferred choice in various clinical applications.

Based on application into: Oncology, Diabetes, Cardiovascular Disease, Autoimmune Disease and Others. The diabetes segment accounted for the largest market share in 2023. On-body injectors are wearable drug delivery devices designed to administer medications over an extended period, enhancing patient convenience and compliance. In oncology, they deliver precise doses of chemotherapy drugs, minimizing hospital visits. For diabetes, they ensure controlled insulin delivery, providing a flexible alternative to traditional injections. In cardiovascular diseases, these devices administer anticoagulants or other critical drugs to manage conditions effectively. Autoimmune diseases benefit from on-body injectors for regular biologic therapies, reducing the need for frequent clinical visits. Additionally, they are used in other therapeutic areas like pain management and hormone therapies, offering reliable and personalized drug administration solutions.

Based on end-use the market is segmented as Homecare Settings, Hospitals & Clinics and Ambulatory Surgical Centers. The homecare settings segment dominated the market. On-body Injectors are increasingly popular in homecare settings, as they allow patients to safely and easily administer their medications on their own. This convenience reduces the need for frequent healthcare visits, making treatments more accessible and efficient for individuals managing chronic conditions. The rise of these devices in homecare is a key factor contributing to the segment's rapid growth.

On-body Injectors Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. The on-body injectors market is experiencing significant growth due to increasing demand for self-administration drug systems, particularly for chronic diseases such as diabetes and autoimmune conditions. North America dominates the market, driven by advanced healthcare infrastructure and high adoption of innovative technologies. Europe follows closely, fueled by supportive government initiatives and a growing aging population. The Asia-Pacific region is emerging as a key growth area due to rising healthcare investments, expanding patient pools, and increased awareness about advanced drug delivery systems. Meanwhile, the Middle East & Africa and Latin America exhibit steady growth, primarily due to improving healthcare access and infrastructure development.

On-body Injectors Market- Competitive Landscape:

The competitive landscape of the on-body injectors market is marked by the presence of leading healthcare and pharmaceutical companies driving innovation in wearable drug delivery systems. Key players like Medtronic plc, Insulet Corporation, Ypsomed, and West Pharmaceutical Services dominate the market with advanced solutions tailored for chronic disease management. Other notable companies, such as Enable Injections and Becton, Dickinson and Company (BD), focus on precision, user-friendly designs, and integration with digital health platforms. The competition is further fueled by partnerships and acquisitions, enabling companies to expand their portfolios and enhance their technological capabilities to meet growing patient and healthcare demands globally.

Recent Developments:

In February 2024, Coherus BioSciences, Inc. launched its UDENYCA ONBODY, a novel wearable injector for delivering pegfilgrastim, which reduces infection risk during chemotherapy. The device enhances patient convenience by minimizing hospital visits.

In October 2023, the U.S. FDA approved the Empaveli Injector, an on-body injector for the self-administration of pegcetacoplan. This device allows patients to administer their health irrespective of their location.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ON-BODY INJECTORS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Insulet Corporation
BD (Becton, Dickinson and Company)
West Pharmaceutical Services, Inc.
Ypsomed Holding AG
Medtronic plc
Enable Injections
Roche
Eli Lilly and Company
Amgen Inc.
CeQur SA
Others

GLOBAL ON-BODY INJECTORS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

Spring-based
Motor-driven
Rotary Pump
Expanding Battery
Other

GLOBAL ON-BODY INJECTORS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Oncology
Diabetes
Cardiovascular Disease
Autoimmune Disease
Others

GLOBAL ON-BODY INJECTORS MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

Hospitals & Clinics
Home Care Settings
Others

GLOBAL ON-BODY INJECTORS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. On-body Injectors Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. On-body Injectors Market Snippet by Technology
- 2.1.2. On-body Injectors Market Snippet by Application
- 2.1.3. On-body Injectors Market Snippet by End-Use
- 2.1.4. On-body Injectors Market Snippet by Country
- 2.1.5. On-body Injectors Market Snippet by Region
2.2. Competitive Insights

3. On-body Injectors Key Market Trends

3.1. On-body Injectors Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. On-body Injectors Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. On-body Injectors Market Opportunities
3.4. On-body Injectors Market Future Trends

4. On-body Injectors Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. On-body Injectors Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. On-body Injectors Market Landscape

6.1. On-body Injectors Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. On-body Injectors Market - By Technology

7.1. Overview
- 7.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
- 7.1.2. Spring-based
- 7.1.3. Motor-driven
- 7.1.4. Rotary Pump
- 7.1.5. Expanding Battery
- 7.1.6. Other

8. On-body Injectors Market - By Application

8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
- 8.1.2. Oncology
- 8.1.3. Diabetes
- 8.1.4. Cardiovascular Disease
- 8.1.5. Autoimmune Disease
- 8.1.6. Others

9. On-body Injectors Market - By End-Use

9.1. Overview
- 9.1.1. Segment Share Analysis, By End-Use, 2023 & 2032 (%)
- 9.1.2. Homecare Settings
- 9.1.3. Hospitals & Clinics
- 9.1.4. Ambulatory Surgical Centers

10. On-body Injectors Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. On-body Injectors Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. On-body Injectors Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. On-body Injectors Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. On-body Injectors Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. On-body Injectors Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- On-body Injectors Industry

11.1. Competitive Dashboard
- 11.1.1. Competitive Benchmarking
- 11.1.2. Competitive Positioning
11.2. Company Profiles
- 11.2.1. Insulet Corporation
- 11.2.2. BD (Becton, Dickinson and Company)
- 11.2.3. West Pharmaceutical Services, Inc.
- 11.2.4. Ypsomed Holding AG
- 11.2.5. Medtronic plc
- 11.2.6. Enable Injections
- 11.2.7. Roche
- 11.2.8. Eli Lilly and Company
- 11.2.9. Amgen Inc.
- 11.2.10. CeQur SA
- 11.2.11. Others